Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mutat Res. 1996 Dec 12;361(2-3):107-12.

Micronucleated erythrocytes in splenectomized patients with and without chemotherapy.

Author information

  • 1División de Medicina Molecular, Centro de Investigación Biomédica de Occidente, I.M.S.S., Guadalajara, Jalisco, Mexico.

Abstract

The purpose of the present study was to investigate the range of micronucleated erythrocytes (MNE) in peripheral blood from splenectomized patients with and without genotoxic chemotherapy. The erythrocytes were stained with Wright and Giemsa for microscopic observation. To estimate the number of MNE, two series of 10000 erythrocytes per sample were analyzed and averaged. The results expressed as mean +/- standard deviation were as follows: control patients with genotoxic chemotherapy (n = 6) 2.5 +/- 1.5 (range 1 to 5 MNE); splenectomized patients with genotoxic chemotherapy (n = 7) 65.2 +/- 17.7 (range: 47-108) MNE and splenectomized patients without genotoxic chemotherapy (n = 13) 29.5 +/- 5.8 MNE; (range: 18.5-35.6). The MNE number in the patients treated with genotoxic chemotherapy depended on the type of drugs utilized: cyclophosphamide, mitoxantrone, vincristine, busulphan, cytosine arabinoside and hydroxyurea. Upon these results, it is suggested that splenectomized people could be useful in monitoring exposures, and the baseline MNE level would serve as each person's pre-exposure control when either chronic or acute exposure to environmental mutagens is investigated.

PMID:
8980695
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk